methylprednisolone has been researched along with Myeloproliferative Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amigo, ML; Caballero, MD; del Cañizo, C; García, R; Gonzalez, M; Hernández, JM; San Miguel, JF; Vazquez, L | 1 |
| Greul, W; Lozano-Tonkin, C | 1 |
2 other study(ies) available for methylprednisolone and Myeloproliferative Disorders
| Article | Year |
|---|---|
Alternating mini-BEAM/ESHAP as salvage therapy for refractory non-Hodgkin's lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cytarabine; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Methylprednisolone; Middle Aged; Myeloproliferative Disorders; Neutropenia; Salvage Therapy; Survival Rate; Time Factors | 1997 |
[Hypercalcaemic crisis as primary manifestation of acute leukaemia in an adult (author's transl)].
Topics: Blood Cell Count; Blood Urea Nitrogen; Bone Marrow Examination; Bone Resorption; Creatinine; Cyclophosphamide; Diagnosis, Differential; Humans; Hypercalcemia; Hyperparathyroidism; Leukemia; Leukocyte Count; Male; Methenolone; Methylprednisolone; Middle Aged; Myeloproliferative Disorders; Phosphates; Phosphoric Monoester Hydrolases; Uric Acid | 1974 |